Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Anti-tumor necrosis factor treatment in cherubism--clinical, radiological and histological findings in two children.
Hero M, Suomalainen A, Hagström J, Stoor P, Kontio R, Alapulli H, Arte S, Toiviainen-Salo S, Lahdenne P, Mäkitie O.
Bone. 2013 Jan;52(1):347-53. doi: 10.1016/j.bone.2012.10.003. Epub 2012 Oct 12.
Related citations
Mutations of the SH3BP2 gene in 2 families of cherubism.
Tuna EB, Shimizu T, Seymen F, Yildirim M, Gencay K, Maeda T.
Pediatr Dent. 2012 May-Jun;34(3):198-202.
Diagnostic discussion. Cherubism.
Cohen D.
Todays FDA. 2012 Mar-Apr;24(3):28-9, 31-3, 35. No abstract available.
The role of SH3BP2 in the pathophysiology of cherubism.
Reichenberger EJ, Levine MA, Olsen BR, Papadaki ME, Lietman SA.
Orphanet J Rare Dis. 2012 May 24;7 Suppl 1:S5. doi: 10.1186/1750-1172-7-S1-S5. Epub 2012 May 24. Review.
Cherubism: best clinical practice.
Papadaki ME, Lietman SA, Levine MA, Olsen BR, Kaban LB, Reichenberger EJ.
Orphanet J Rare Dis. 2012 May 24;7 Suppl 1:S6. doi: 10.1186/1750-1172-7-S1-S6. Epub 2012 May 24. Review.
Cherubism--a case report with long term follow up.
Chavali LV, Bhimalingam RM, Sudhakar PV.
Indian J Pathol Microbiol. 2011 Oct-Dec;54(4):793-5. doi: 10.4103/0377-4929.91509.
Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease.
Guettler S, LaRose J, Petsalaki E, Gish G, Scotter A, Pawson T, Rottapel R, Sicheri F.
Cell. 2011 Dec 9;147(6):1340-54. doi: 10.1016/j.cell.2011.10.046. Erratum in: Cell. 2012 Jan 20;148(1-2):376.
Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.
Levaot N, Voytyuk O, Dimitriou I, Sircoulomb F, Chandrakumar A, Deckert M, Krzyzanowski PM, Scotter A, Gu S, Janmohamed S, Cong F, Simoncic PD, Ueki Y, La Rose J, Rottapel R.
Cell. 2011 Dec 9;147(6):1324-39. doi: 10.1016/j.cell.2011.10.045.
Multidisciplinary surgical management of cherubism complicated by neurofibromatosis type 1.
Hachach-Haram N, Gerarchi P, Benyon SL, Saggar A, McLellan G, Kirkpatrick WN.
J Craniofac Surg. 2011 Nov;22(6):2318-22. doi: 10.1097/SCS.0b013e318232a779.
Enhancement of B-cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubism.
Ogi K, Nakashima K, Chihara K, Takeuchi K, Horiguchi T, Fujieda S, Sada K.
Genes Cells. 2011 Sep;16(9):951-60. doi: 10.1111/j.1365-2443.2011.01539.x. Epub 2011 Jul 28.
Management of a patient suffering with Cherubism with dental implants.
Dewan K, Bishop K.
Eur J Prosthodont Restor Dent. 2011 Jun;19(2):67-71.
SH3BP2-encoding exons involved in cherubism are not associated with central giant cell granuloma.
Teixeira RC, Horz HP, Damante JH, Garlet GP, Santos CF, Nogueira RL, Cavalcante RB, Conrads G.
Int J Oral Maxillofac Surg. 2011 Aug;40(8):851-5. doi: 10.1016/j.ijom.2011.04.003. Epub 2011 Jun 16.
The surgical and orthodontic management of cherubism in a growing child.
Kau CH, Souccar NM, English JD, Kamel SG, Wong ME.
J Craniomaxillofac Surg. 2012 Apr;40(3):229-33. doi: 10.1016/j.jcms.2011.04.012. Epub 2011 Jun 14.
Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism.
Pagnini I, Simonini G, Mortilla M, Giani T, Pascoli L, Cimaz R.
Clin Exp Rheumatol. 2011 Jan-Feb;29(1):147. Epub 2011 Feb 23. No abstract available.
Orthognathic surgery in cherubism.
Hernández-Alfaro F, Arenaz Búa J, Mareque Bueno J, Badía C.
J Oral Maxillofac Surg. 2011 Feb;69(2):541-5. doi: 10.1016/j.joms.2010.07.065. No abstract available.
Postpubertal nonfamilial cherubism and teeth transposition.
Ozan B, Muğlali M, Celenk P, Günhan O.
J Craniofac Surg. 2010 Sep;21(5):1575-7. doi: 10.1097/SCS.0b013e3181ecc529.
Fine needle aspiration cytologic features of Cherubism: a case report.
Gupta N, Duggal R, Rajwanshi A, Rattan V.
Acta Cytol. 2010 Jul-Aug;54(4):595-7.
Cherubism combined with epilepsy, mental retardation and gingival fibromatosis (Ramon syndrome): a case report.
Suhanya J, Aggarwal C, Mohideen K, Jayachandran S, Ponniah I.
Head Neck Pathol. 2010 Jun;4(2):126-31. doi: 10.1007/s12105-009-0155-9. Epub 2009 Dec 11.
NFATc1 and TNFalpha expression in giant cell lesions of the jaws.
Amaral FR, Brito JA, Perdigão PF, Carvalho VM, de Souza PE, Gomez MV, De Marco L, Gomez RS.
J Oral Pathol Med. 2010 Mar;39(3):269-74. doi: 10.1111/j.1600-0714.2009.00855.x. Epub 2009 Dec 11.
Unexpected matrix diseases and novel therapeutic strategies.
Nicolae C, Olsen BR.
Cell Tissue Res. 2010 Jan;339(1):155-65. doi: 10.1007/s00441-009-0874-y. Epub 2009 Oct 8. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on